ProSomnus, Inc.
OSANASDAQHealthcare
$0.47
+$0.00(+0.00%)
Market Cap$8175227
P/E Ratio—
52W High$0.5
52W Low$0.47
ProSomnus, Inc.（OSA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · OSA · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $27.65M | $19.39M | $14.07M | $8.29M |
| Cost of Revenue | $13.64M | $9.13M | $6.76M | $4.17M |
| Gross Profit | $14.01M | $10.27M | $7.31M | $4.12M |
| Gross Margin %(computed) | 50.67% | 52.94% | 51.94% | 49.73% |
| Operating Expenses | ||||
| R&D Expenses | $4.80M | $2.98M | $1.89M | $1.47M |
| G&A Expenses | $15.23M | $9.89M | $4.46M | $3.29M |
| Total Operating Expenses | $33.12M | $21.74M | $12.13M | $8.28M |
| Operating Income | ($19.11M) | ($1.03M) | ($4.81M) | ($4.15M) |
| Operating Margin %(computed) | -69.09% | -5.29% | -34.21% | -50.06% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $7.86M | $6.12M | $3.25M | $2.01M |
| Income Before Tax | ($24.09M) | ($7.15M) | ($5.97M) | ($6.16M) |
| Income Tax Expense | $0.00M | ($10.45M) | $0.01M | $0.02M |
| Net Income | ($24.09M) | $3.30M | ($5.98M) | ($6.17M) |
| Net Margin %(computed) | -87.14% | 17.04% | -42.47% | -74.50% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-1.49 | $0.33 | $-1.51 | $-0.38 |
| Wtd Avg Shares | 16.18M | 10.02M | 3.96M | 16.05M |
| EBITDA | ($17.73M) | ($11.48M) | ($1.90M) | ($3.57M) |
| EBITDA Margin %(computed) | -64.14% | -59.17% | -13.53% | -43.14% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解ProSomnus, Inc.
关于ProSomnus, Inc.（OSA）损益表
ProSomnus, Inc.（OSA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年，OSA实现营收$0.03B，毛利润$0.01B（毛利率50.67%），净利润($0.02B)（净利率-87.14%）。
常见问题
OSA · 4 问ProSomnus, Inc.（OSA）2023财年营收为$0.03B，同比up42.6%。
OSA revenueOSA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09